Benzinga | Nov 11, 2020 06:10AM EST

Wells Fargo Upgrades Five Prime Therapeutics to Overweight, Announces $34 Price Target

Wells Fargo analyst Jim Birchenough upgrades Five Prime Therapeutics (NASDAQ:FPRX) from Equal-Weight to Overweight and announces $34 price target.